Press release
AI-based Clinical Trials Market worth $21.79 billion by 2030, growing at a CAGR of 18.79% - Exclusive Report by 360iResearch
AI-based Clinical Trials Market | 360iResearch
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/ai-based-clinical-trials?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Artificial Intelligence (AI)-based clinical trials enhance various aspects of clinical research, including patient recruitment, trial design, data collection, and analysis, by integrating machine learning (ML) algorithms and natural language processing (NLP) tools to improve efficiency, cost-effectiveness, and accuracy. These trials are necessary for their potential to streamline processes, reduce time and costs, enhance data accuracy, expedite patient recruitment, and enable predictive analysis. Applications include scanning medical records for patient suitability, designing adaptive trials, continuous health monitoring via wearable devices, and managing large datasets for precise insights. End-users encompass pharmaceutical companies, Clinical Research Organizations (CROs), healthcare providers, and regulatory bodies. Key growth drivers are technological advancements, rising healthcare costs, increasing prevalence of chronic diseases, and a supportive regulatory environment. Potential opportunities lie in personalized medicine, remote monitoring, big data integration, and global expansion. Recommendations for leveraging these opportunities include investing in advanced AI technologies, collaborating with tech firms and academic institutions, focusing on user-friendly tools, and ensuring regulatory compliance. Limitations and challenges comprise data privacy issues, high initial costs, technical complexity, regulatory hurdles, variable data quality, and ethical concerns. Areas ripe for innovation include predictive modeling, automated data collection through IoT devices, adaptive trial design, and developing interoperable AI systems. The market is characterized by rapid growth, significant innovation, and a competitive landscape driven by the need for more efficient and effective clinical trial processes, with collaboration among stakeholders being crucial for sustained progress. Addressing limitations and capitalizing on opportunities can significantly advance AI-based clinical trials, driving market growth and improved healthcare outcomes.
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/ai-based-clinical-trials?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
Market Segmentation & Coverage:
This research report categorizes the AI-based Clinical Trials Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Component, market is studied across Services and Software.
Based on Function, market is studied across Adverse Event Detection, Data Collection & Analysis, Patient Recruitment & Screening, Predictive Modeling, and Trial Design & Optimization.
Based on Phase, market is studied across Phase-I, Phase-II, and Phase-III.
Based on Technology, market is studied across Machine Learning and Natural Language Processing.
Based on Application, market is studied across Cardiovascular Diseases, Infectious Diseases, Metabolic Diseases, Neurological Diseases, and Oncology.
Based on End-user, market is studied across Academic & Research Institutes, Contract Research Organization, Hospitals, and Pharmaceutical & Biopharmaceutical Companies.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Key Company Profiles:
The report delves into recent significant developments in the AI-based Clinical Trials Market, highlighting leading vendors and their innovative profiles. These include AiCure, LLC, Aiforia Technologies Oyj, Antidote Technologies, Inc., Ardigen S.A., Avantor, Inc., BioAge Labs, BioSymetrics Inc., Deep 6 AI Inc., Envisagenics, Euretos Services BV, Exscientia PLC, GNS Healthcare, Google LLC by Alphabet Inc., Innoplexus AG, InSilico Medicine, Intel Corporation, International Business Machines Corporation, Koninklijke Philips N.V., Median Technologies, Nuritas Limited, Pharmaceutical Pipeline Enhancement Strategies, LLC, Saama Technologies, Inc., Symplr Software LLC, Trials.ai, Inc. by ZS Associates, Inc., and Unlearn.AI, Inc..
Introducing ThinkMi Query: Revolutionizing Market Intelligence with AI-Powered Insights for the AI-based Clinical Trials Market
We proudly unveil ThinkMi Query, a cutting-edge AI product designed to transform how businesses interact with the AI-based Clinical Trials Market. ThinkMi Query stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, ThinkMi Query is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it's a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive AI-based Clinical Trials Market. Embrace the future of market analysis with ThinkMi Query, where informed decisions lead to remarkable growth.
Ask Question to ThinkMi Query @ https://www.360iresearch.com/library/intelligence/ai-based-clinical-trials?utm_source=openpr&utm_medium=referral&utm_campaign=query
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. AI-based Clinical Trials Market, by Component
7. AI-based Clinical Trials Market, by Function
8. AI-based Clinical Trials Market, by Phase
9. AI-based Clinical Trials Market, by Technology
10. AI-based Clinical Trials Market, by Application
11. AI-based Clinical Trials Market, by End-user
12. Americas AI-based Clinical Trials Market
13. Asia-Pacific AI-based Clinical Trials Market
14. Europe, Middle East & Africa AI-based Clinical Trials Market
15. Competitive Landscape
16. Competitive Portfolio
Read More @ https://www.360iresearch.com/library/intelligence/ai-based-clinical-trials?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AI-based Clinical Trials Market worth $21.79 billion by 2030, growing at a CAGR of 18.79% - Exclusive Report by 360iResearch here
News-ID: 3583590 • Views: …
More Releases from 360iResearch
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Trial
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Clinical Trial Imaging market
The Clinical Trial Imaging market crossed the US$ 1.09 billion mark in 2022 and is expected to hit US$ 1.94 billion by 2030, recording a CAGR of 7.5% during the forecast period.
Rising R&D spending, a rapidly growing pharmaceutical industry, and an increase in the number of contract research organizations are some of the major factors driving the market's growth. There has been an increase in pharmaceutical companies due to the…
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019.
Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
…
Clinical Trial Logistics
Clinical Trial Logistics
16th to 17th May 2011, Marriott Regents Park, London, United Kingdom.
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials…
Clinical Trial Logistics
Announcing SMi's 5th annual…
Clinical Trial Logistics conference
16th and 17th May 2011, Central London, UK
www.smi-online.co.uk/2011logistics-london6.asp
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical…
